Bone-protective effects of everolimus for premenopausal HR+/HER2-neg metastatic breast cancer June 15, 2021
A phase I study of alpelisib + trastuzumab + LJM716 for PIK3CA-mutated HER2+ metastatic breast cancer June 14, 2021